Technology | May 25, 2011

Wireless DR System Receives 510(k)

May 25, 2011 - The U.S. Food and Drug Administration (FDA) has given 510(k) clearance and commercial availability of the Fujifilm Medical Systems’s FDR D-EVO Wireless. This new wireless version of the company's flat panel detector will deliver Fujifilm's image quality in a lightweight design for enhanced versatility and greater ease of positioning in a wider variety of imaging applications. The FDR D-EVO Wireless will be featured along with Fujifilm's complete product line-up, including the Synapse portfolio, at the Society for Imaging Informatics in Medicine (SIIM) 2011 Annual Meeting June 2-5 in Washington, D.C.

Like its corded predecessor, the FDR D-EVO, the FDR D-EVO Wireless offers Fujifilm's image quality while also enabling facilities to achieve significant dose efficiency improvements. The flat panel detector uses Fujifilm's patented Irradiation Side Sampling (ISS), a technology that improves detective quantum efficiency (DQE) and enables technologists to take high-quality images at lower doses. This design reduces scatter and blur of X-rays captured, resulting in sharper images with greater detail, which enhances diagnostic confidence for the radiologist. The wireless detector is the ideal solution for exams where low-dose is required to produce the fine details for images of delicate areas, such as orthopaedic exams of the wrist, hand or leg.

In addition to providing flexibility during an exam with its light weight and no cord to interfere, the FDR D-EVO Wireless also offers a lasting power supply that will reduce downtime and increase throughput. The system offers a lightweight removable lithium ion battery that provides fast charge times and up to three hours or 400 exposures of use per charge. A multi-charger system with two spare batteries is also included with the detector, which reduces concerns for power loss. Additionally, a detachable cord provides the option for continuous charging and the ability to leave the detector in the bucky for uninterrupted extended use.

For more information: www.fujimed.com

Related Content

This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

News | Coronavirus (COVID-19) | June 26, 2020
June 26, 2020 — In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association wit
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...
Advanced imaging data exchange is now live in Colorado due to the partnership of Health Images and the Colorado Regional Health Information Organization

Getty Images

News | Radiology Business | May 18, 2020
May 18, 2020 — 
World’s largest deployment of a radiology-based AI diagnostic solution for COVID-19 using AI-based chest X-ray technology
News | Coronavirus (COVID-19) | May 18, 2020
May 18, 2020 — Behold.ai announced its partnership with Ap...
Chest radiograph of a 23-year-old male with no past medical history who tested positive for COVID-19 via RT-PCR and was subsequently discharged from the emergency department with home care and isolation precautions. Portable CXR shows right and left peripheral lower lung zone hazy opacities; total score=2

Top image: Chest radiograph of a 23-year-old male with no past medical history who tested positive for COVID-19 via RT-PCR and was subsequently discharged from the emergency department with home care and isolation precautions. Portable CXR shows right and left peripheral lower lung zone hazy opacities; total score=2.

Bottom image: Chest radiograph in a 32-year-old overweight (BMI=30) COVID-19 positive male with a history of childhood asthma who was subsequently admitted and intubated in the ICU for 3 days. Portable CXR shows opacities in all three right lung zones and in the left middle and lower lung zones; total score=5. Image courtesy of Mount Sinai Health System

News | Coronavirus (COVID-19) | May 15, 2020
May 15, 2020 — Chest X-rays performed on young and
Zegami, the Oxford University data visualization spin-out, has announced it has written to the health ministers of ten countries asking them to provide X-rays of COVID-19 infected lungs.
News | Coronavirus (COVID-19) | April 27, 2020
April 27, 2020 — Zegami, the Oxford University data visualization s